Category: MassDevice sales & earnings roundup

Analogic's medical business flat in Q2

March 10, 2010 by MassDevice staff

Analogic Corp.'s (NSDQ:ALOG) largest business segment posted flat sales, with a 9 percent dip in its bread-and-butter MRI and CT equipment business offsetting stronger sales of specialized ultrasound equipment.

The Peabody, Mass.-based imaging equipment maker posted sales of $103.3 million for the three months ended Jan. 31, essentially flat compared with $102.7 million during the same period last year. Still, net income improved to $3.6 million, compared to $1.4 million for the same period last year, when the company took a $3.5 million hit to its bottom line when it laid off 145 employees, or about 9 percent of its total workforce.

LeMaitre ends 2009 in the black

March 4, 2010 by MassDevice staff

LeMaitre Vascular Inc. (NSDQ:LMAT) ended 2009 swinging from red to black, riding strong sales in its vascular division to positive top- and bottom-line growth for the year.

The Burlington, Mass.-based peripheral vascular device maker posted sales of $13.6 million during the three months ended Dec. 31, 2009, up 13 percent compared with the $12 million in sales the company reported during the same period in 2008.

The increased sales helped the company boost its bottom line to $1.3 million, compared to a $312,000 profit for Q4 2008.

Volcano swings to Q4 loss despite 45 percent increase in sales

March 4, 2010 by MassDevice staff

Volcano Corp. (NSDQ:VOLC) posted $71 million in sales during the fourth quarter, a 45 percent increase from the $49 million it posted during the same period last year.

However, the San Diego-based maker of intravascular therapy devices slipped into the red during the three months ended Dec. 31, 2009, posting a net loss of $12 million, compared to a $1.3 million profit for the same period in 2008.

Officials blamed the quarterly loss on $14 million worth of "in-process" R&D charges it assumed when the company acquired CardioSpectra Inc. and Novelis Inc., according to its earnings release.

ATS Medical trims net loss by 68 percent in 2009

March 2, 2010 by MassDevice staff

ATS Medical Inc. (NSDQ:ATSI) reported sales of $18.7 million during the fourth quarter, an increase of 4 percent when compared to the $18 million the company reported during the same period in 2008.

The Minneapolis, Minn.-based heart valve repair products company managed to trim its net loss to $3.4 million for the three months ended Dec. 31, 2009, a 62 percent decrease from the $8.5 million the company lost during the same period last year.

For the year, ATS managed to narrow its net losses by 68 percent, reporting a loss of just over $6 million on $75 million in sales, compared to a $19 million loss on $66 million in sales during 2008.

Denville acquisition pays off for Harvard Bioscience in Q4

February 26, 2010 by MassDevice staff

Harvard Bioscience Inc. (NSDQ:HBIO) is seeing some returns from its $24 million acquisition of Denville Scientific Inc.

The Holliston, Mass.-based lab instruments maker said revenues from its new Denville subsidiary contributed $5.7 million in sales during the three months ended Dec. 31, 2009. In all, revenues from Denville made up about 20 percent of the $27.6 million in sales the company reported during the quarter; during the same period last year the company posted $23 million in sales.

NuVasive reverses $27 million loss from 2008 on 48 percent jump in sales

February 26, 2010 by MassDevice staff

NuVasive Inc. (NSDQ:NUVA) rode a nearly 50 percent increase in 2009 sales to turn a $27 million loss in 2008 into a $5 million profit last year.

The San Diego-based company, which is developing what it calls "minimally disruptive" spine surgery techniques, said its sales for the three months ended Dec. 31, 2009, were $107 million, a 43 percent increase from the $75 million the company posted for the fourth quarter of 2008.

NxStage Medical builds revenues, narrows Q4 losses

February 25, 2010 by MassDevice staff

NxStage Medical Inc. saw impressive gains in its home- and critical-care businesses during the fourth quarter, helping offset a slight decline in consumables sales and leading the manufacturer of home dialysis equipment to a smaller net loss during the three months ended Dec. 31, 2009, compared with year-ago levels.